Endo International PLC (ENDPQ)

0.1054
-0.0125(-10.60%)
After Hours
0.1053
-0.0001(-0.0949%)
- Delayed Data
  • Volume:
    4,697,746
  • Bid/Ask:
    0.0000/0.0000
  • Day's Range:
    0.1020 - 0.1179

ENDPQ Overview

Prev. Close
0.1179
Day's Range
0.102-0.1179
Revenue
2.78B
Open
0.1179
52 wk Range
0.092-7.0652
EPS
-11.09
Volume
4,697,746
Market Cap
25.84M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
47,942,682
P/E Ratio
-0.037
Beta
1.15
1-Year Change
-96.92%
Shares Outstanding
235,142,889
Next Earnings Date
Nov 10, 2022
What is your sentiment on Endo Int?
or
Market is currently closed. Voting is open during market hours.

Endo International PLC News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Endo International PLC Analysis

Endo International PLC Company Profile

Endo International PLC Company Profile

Employees
3103

Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States and internationally. Its Branded Pharmaceuticals segment provides branded prescription products, including XIAFLEX to treat adult patients with Dupuytren’s contracture; SUPPRELIN LA to treat central precocious puberty in children; NASCOBAL nasal spray to treat vitamin B12 deficiency; AVEED to treat hypogonadism; QWO, an injectable treatment for moderate to severe cellulite in the buttocks of adult women; PERCOCET to treat moderate-to-moderately-severe pain; TESTOPEL an implantable pellet indicated for TRT in conditions associated with a deficiency or absence of endogenous testosterone; EDEX to treat erectile dysfunction; LIDODERM a topical patch product containing lidocaine for the relief of pain; and products for the pain management and urology. The company’s Sterile Injectables segment manufactures VASOSTRICT, a vasopressin injection; ADRENALIN, a non-selective adrenergic agonist; and APLISOL, which is a sterile aqueous solution, as well as generic sterile injectable products, including ertapenem for injections and ephedrine sulfate injections. Its Generic Pharmaceuticals segment offers solid oral extended-release, solid oral immediate-release, liquids, semi-solids, patches, powders, ophthalmic products, and sprays. The company’s International Pharmaceuticals segment offers specialty pharmaceutical products in various therapeutic areas comprising attention deficit hyperactivity disorder, pain, women’s health, oncology, and transplantation. The company sells its branded pharmaceuticals and generics to specialty physicians, retailers, clinics, government agencies, doctors, retail and specialty pharmacies, and specialty distributors. Endo International plc was founded in 1920 and is headquartered in Dublin, Ireland. On August 16, 2022, Endo International plc, along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of New York.

Read More

Analyst Price Target

Average1.3333 (+1164.99% Upside)
High2
Low1
Price0.1054
No. of Analysts3
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralSellSellStrong SellStrong Sell
Technical IndicatorsBuySellStrong SellStrong SellStrong Sell
SummaryNeutralSellStrong SellStrong SellStrong Sell
  • Whats happen ?
    0
    • 30% a mercato chiuso.
      0
    • Oggi 40% a mercato aperto - grandi!
      0
  • Reverse splitting coming?
    0
    • Go 1
      2
      • Endo to the moon
        4
        • Why did this jump so much pre market then dive???
          1
          • Profit is profit, thats why its always good to just shut the computer off ater closing a position. Reason is I could have made double if I just waited a few more minutes to sell uugh lol.
            1
            • Endo to the moon jumped back in and made some more haha!
              0
          • Made a few hundred this morning off this dont know why its up pre market like it was.
            0
            • what is happening? why of this huge loss
              0
              • Debt restructuring: not bad news in itself.
                0
              • yes... but they sold their properties in USA too
                0
            • Markt Miràcle Advisor published an input signal with a first target at 3.54
              0
              • yay
                0